Brain-selective overexpression of angiotensin (AT1) receptors causes enhanced cardiovascular sensitivity in transgenic mice

Eric Lazartigues, Shannon M Dunlay, Angela K. Loihl, Puspha Sinnayah, Julie A. Lang, Joshua J. Espelund, Curt D. Sigmund, Robin L. Davisson

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

To examine the physiological importance of brain angiotensin II type 1 (AT1) receptors, we developed a novel transgenic mouse model with rat AT1a receptors targeted selectively to neurons of the central nervous system (CNS). A transgene consisting of 2.8 kb of the rat neuron-specific enolase (NSE) 5′ flanking region fused to a cDNA encoding the full open-reading frame of the rat AT1a receptor was constructed and transgenic mice (NSE-AT1a) were generated. Two of six transgenic founder lines exhibited brain-selective expression of the transgene at either moderate or high levels. Immunohistochemistry revealed widespread distribution of AT1 receptors in neurons throughout the CNS. This neuron-targeted overexpression of AT1a receptors resulted in enhanced cardiovascular responsiveness to intracerebroventricular (ICV) angiotensin II (Ang II) injection but not to other central pressor agents, demonstrating functional overexpression of the transgene in NSE-AT1a mice. Interestingly, baseline blood pressure (BP) was not elevated in either transgenic line. However, blockade of central AT1 receptors with ICV losartan caused significant falls in basal BP in NSE-AT1a mice but had no effect in nontransgenic controls. These results suggest that whereas there is an enhanced contribution of central AT1 receptors to the maintenance of baseline BP in NSE-AT1a mice, particularly effective baroreflex buffering prevents hypertension in this model. Used both independently, and in conjunction with mice harboring gene-targeted deletions of AT1a receptors, this new model will permit quantitative and relevant investigations of the role of central AT1a receptors in cardiovascular homeostasis in health and disease.

Original languageEnglish (US)
Pages (from-to)617-624
Number of pages8
JournalCirculation Research
Volume90
Issue number5
DOIs
StatePublished - Mar 22 2002
Externally publishedYes

Fingerprint

Angiotensin Type 1 Receptor
Phosphopyruvate Hydratase
Angiotensins
Transgenic Mice
Transgenes
Brain
Blood Pressure
Neurons
Central Nervous System
Losartan
Baroreflex
5' Flanking Region
Gene Deletion
Angiotensin II
Open Reading Frames
Homeostasis
Complementary DNA
Immunohistochemistry
Maintenance
Hypertension

Keywords

  • Blood pressure
  • Central nervous system
  • Hypertension
  • Neurons
  • Renin-angiotensin system

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Brain-selective overexpression of angiotensin (AT1) receptors causes enhanced cardiovascular sensitivity in transgenic mice. / Lazartigues, Eric; Dunlay, Shannon M; Loihl, Angela K.; Sinnayah, Puspha; Lang, Julie A.; Espelund, Joshua J.; Sigmund, Curt D.; Davisson, Robin L.

In: Circulation Research, Vol. 90, No. 5, 22.03.2002, p. 617-624.

Research output: Contribution to journalArticle

Lazartigues, Eric ; Dunlay, Shannon M ; Loihl, Angela K. ; Sinnayah, Puspha ; Lang, Julie A. ; Espelund, Joshua J. ; Sigmund, Curt D. ; Davisson, Robin L. / Brain-selective overexpression of angiotensin (AT1) receptors causes enhanced cardiovascular sensitivity in transgenic mice. In: Circulation Research. 2002 ; Vol. 90, No. 5. pp. 617-624.
@article{f374324557bf46d8b14fdff512ae8e25,
title = "Brain-selective overexpression of angiotensin (AT1) receptors causes enhanced cardiovascular sensitivity in transgenic mice",
abstract = "To examine the physiological importance of brain angiotensin II type 1 (AT1) receptors, we developed a novel transgenic mouse model with rat AT1a receptors targeted selectively to neurons of the central nervous system (CNS). A transgene consisting of 2.8 kb of the rat neuron-specific enolase (NSE) 5′ flanking region fused to a cDNA encoding the full open-reading frame of the rat AT1a receptor was constructed and transgenic mice (NSE-AT1a) were generated. Two of six transgenic founder lines exhibited brain-selective expression of the transgene at either moderate or high levels. Immunohistochemistry revealed widespread distribution of AT1 receptors in neurons throughout the CNS. This neuron-targeted overexpression of AT1a receptors resulted in enhanced cardiovascular responsiveness to intracerebroventricular (ICV) angiotensin II (Ang II) injection but not to other central pressor agents, demonstrating functional overexpression of the transgene in NSE-AT1a mice. Interestingly, baseline blood pressure (BP) was not elevated in either transgenic line. However, blockade of central AT1 receptors with ICV losartan caused significant falls in basal BP in NSE-AT1a mice but had no effect in nontransgenic controls. These results suggest that whereas there is an enhanced contribution of central AT1 receptors to the maintenance of baseline BP in NSE-AT1a mice, particularly effective baroreflex buffering prevents hypertension in this model. Used both independently, and in conjunction with mice harboring gene-targeted deletions of AT1a receptors, this new model will permit quantitative and relevant investigations of the role of central AT1a receptors in cardiovascular homeostasis in health and disease.",
keywords = "Blood pressure, Central nervous system, Hypertension, Neurons, Renin-angiotensin system",
author = "Eric Lazartigues and Dunlay, {Shannon M} and Loihl, {Angela K.} and Puspha Sinnayah and Lang, {Julie A.} and Espelund, {Joshua J.} and Sigmund, {Curt D.} and Davisson, {Robin L.}",
year = "2002",
month = "3",
day = "22",
doi = "10.1161/01.RES.0000012460.85923.F0",
language = "English (US)",
volume = "90",
pages = "617--624",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Brain-selective overexpression of angiotensin (AT1) receptors causes enhanced cardiovascular sensitivity in transgenic mice

AU - Lazartigues, Eric

AU - Dunlay, Shannon M

AU - Loihl, Angela K.

AU - Sinnayah, Puspha

AU - Lang, Julie A.

AU - Espelund, Joshua J.

AU - Sigmund, Curt D.

AU - Davisson, Robin L.

PY - 2002/3/22

Y1 - 2002/3/22

N2 - To examine the physiological importance of brain angiotensin II type 1 (AT1) receptors, we developed a novel transgenic mouse model with rat AT1a receptors targeted selectively to neurons of the central nervous system (CNS). A transgene consisting of 2.8 kb of the rat neuron-specific enolase (NSE) 5′ flanking region fused to a cDNA encoding the full open-reading frame of the rat AT1a receptor was constructed and transgenic mice (NSE-AT1a) were generated. Two of six transgenic founder lines exhibited brain-selective expression of the transgene at either moderate or high levels. Immunohistochemistry revealed widespread distribution of AT1 receptors in neurons throughout the CNS. This neuron-targeted overexpression of AT1a receptors resulted in enhanced cardiovascular responsiveness to intracerebroventricular (ICV) angiotensin II (Ang II) injection but not to other central pressor agents, demonstrating functional overexpression of the transgene in NSE-AT1a mice. Interestingly, baseline blood pressure (BP) was not elevated in either transgenic line. However, blockade of central AT1 receptors with ICV losartan caused significant falls in basal BP in NSE-AT1a mice but had no effect in nontransgenic controls. These results suggest that whereas there is an enhanced contribution of central AT1 receptors to the maintenance of baseline BP in NSE-AT1a mice, particularly effective baroreflex buffering prevents hypertension in this model. Used both independently, and in conjunction with mice harboring gene-targeted deletions of AT1a receptors, this new model will permit quantitative and relevant investigations of the role of central AT1a receptors in cardiovascular homeostasis in health and disease.

AB - To examine the physiological importance of brain angiotensin II type 1 (AT1) receptors, we developed a novel transgenic mouse model with rat AT1a receptors targeted selectively to neurons of the central nervous system (CNS). A transgene consisting of 2.8 kb of the rat neuron-specific enolase (NSE) 5′ flanking region fused to a cDNA encoding the full open-reading frame of the rat AT1a receptor was constructed and transgenic mice (NSE-AT1a) were generated. Two of six transgenic founder lines exhibited brain-selective expression of the transgene at either moderate or high levels. Immunohistochemistry revealed widespread distribution of AT1 receptors in neurons throughout the CNS. This neuron-targeted overexpression of AT1a receptors resulted in enhanced cardiovascular responsiveness to intracerebroventricular (ICV) angiotensin II (Ang II) injection but not to other central pressor agents, demonstrating functional overexpression of the transgene in NSE-AT1a mice. Interestingly, baseline blood pressure (BP) was not elevated in either transgenic line. However, blockade of central AT1 receptors with ICV losartan caused significant falls in basal BP in NSE-AT1a mice but had no effect in nontransgenic controls. These results suggest that whereas there is an enhanced contribution of central AT1 receptors to the maintenance of baseline BP in NSE-AT1a mice, particularly effective baroreflex buffering prevents hypertension in this model. Used both independently, and in conjunction with mice harboring gene-targeted deletions of AT1a receptors, this new model will permit quantitative and relevant investigations of the role of central AT1a receptors in cardiovascular homeostasis in health and disease.

KW - Blood pressure

KW - Central nervous system

KW - Hypertension

KW - Neurons

KW - Renin-angiotensin system

UR - http://www.scopus.com/inward/record.url?scp=0037155772&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037155772&partnerID=8YFLogxK

U2 - 10.1161/01.RES.0000012460.85923.F0

DO - 10.1161/01.RES.0000012460.85923.F0

M3 - Article

VL - 90

SP - 617

EP - 624

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 5

ER -